Form 8-K - Current report:
SEC Accession No. 0001144204-18-047697
Filing Date
2018-09-04
Accepted
2018-09-04 08:00:33
Documents
3
Period of Report
2018-09-04
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tv502214_8k.htm 8-K 16070
2 EXHIBIT 99.1 tv502214_ex99-1.htm EX-99.1 12689
3 GRAPHIC image_001.jpg GRAPHIC 9884
  Complete submission text file 0001144204-18-047697.txt   43639
Mailing Address 400 OYSTER POINT BLVD SUITE 505 SAN FRANCISCO CA 94080
Business Address 400 OYSTER POINT BLVD SUITE 505 SAN FRANCISCO CA 94080 6502444990
TITAN PHARMACEUTICALS INC (Filer) CIK: 0000910267 (see all company filings)

EIN.: 943171940 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-13341 | Film No.: 181051276
SIC: 2836 Biological Products, (No Diagnostic Substances)